Singapore: Australia Patrys, a clinical stage biopharmaceutical company, has received approval to commence its planned P...
Singapore: Novartis and Malaria No More, a leading global charity to end malaria deaths, are joining forces on the Power...
Singapore: An experimental treatment for alcohol dependence works better in individuals who possess specific combination...
Singapore: Merck has partnered with Kenya Medical Research Institution (KEMRI) for scientific research and development p...
Singapore: Shionogi, one of Japan's biggest pharmaceutical companies, has signed a memorandum of understanding (MoU) for...
Singapore: Merck, which is known as MSD outside the US and Canada, revealed positive results from its phase Ib study sho...
Singapore: Viralytics has finalized the clinical study report on the phase I evaluation of Cavatak, which is administere...
Singapore: US based Forest Laboratories plans to acquire exclusive rights in the United States for Saphris (asenapine) s...
Singapore: The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's vaccine MenHibrix (meningococcal gr...
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted a second Australian patent f...
Singapore: Vanderbilt University, US, and Bristol-Myers Squibb signed a collaboration agreement for the R&D and comm...
Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food and Drug Administratio...
Singapore: It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year o...
Singapore: A study conducted by Beike Biotechnology Company in conjunction with physicians and researchers at two Chines...
Singapore: Autism results from abnormal cell communication. Testing a new theory, researchers at the University of Calif...
Singapore: Boehringer Ingelheim and the Institute of Molecular Health Science and the Institute of Food, Nutrition and H...
Singapore: A new study by researchers at Columbia University Medical Center, US, revealed that injection of triglyceride...
Singapore: Dicerna Pharmaceuticals, a RNA interference (RNAi) company focused on developing breakthrough oncology thera...
